Mitophagy is required for cell survival upon ultrasound and microbubble therapeutic exposure
- 1Toronto Metropoiltan University
Abstract
Ultrasound-stimulated microbubble (USMB) sonoporation treatment is an emerging strategy for cancer therapy that enhances drug delivery by perforating the plasma membrane. This membrane permeabilization also causes cellular metabolic stress as cells leak metabolites such as ATP and amino acids. Collectively, cells may die in response to excess membrane damage and stress. However, many cells survive the USMB insult by engaging membrane repair and adaptation pathways such as stimulation of AMPK. In this study, we investigated the impact of USMB treatment on mitochondria and their role in post-exposure cellular survival. We found that USMB causes mitochondrial fragmentation and decreases mitochondrial membrane potential. Subsequently, autophagy and Parkin-dependent mitophagy are triggered post-USMB treatment in an AMPK-dependent mechanism. Importantly, Parkin silencing and PINK1 inhibition augment cell death when combined with USMB exposure, suggesting that mitophagy is an important cell survival process in response to USMB. We propose that combining USMB with inhibitors of mitophagy and metabolic stress adaptation is a strong candidate for therapeutic development to treat solid tumours.
Related
- Geranylgeranylation is required for B-cell proliferation and plasma cell survival implications for autoimmune therapy
- Meis2 is required for GABAergic amacrine cell survival in the developing retina.
- SIM2s coordinates programmed mitophagy with respiratory chain supercomplex remodeling during mammary epithelial differentiation
- Trigeminal Nerve Stimulation Attenuates Traumatic Brain Injury-Induced Neuronal Damage via CGRP-PINK1 Mitophagy Axis
- The GSNOR1-VDAC3 complex acts as a cargo co-receptor for mitophagy in response to mitochondrial stress in plants
BibTeX
@misc{cloves2026mitophagy,
title = {{Mitophagy is required for cell survival upon ultrasound and microbubble therapeutic exposure}},
author = {E. Cloves and S. A. Kamil and N. Mayassi and A. Pinto and R. Karshafian and C. N. Antonescu and R. J. Botelho},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.17.759693},
url = {https://www.biorxiv.org/content/10.64898/2026.10.17.759693v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Mitophagy is required for cell survival upon ultrasound and microbubble therapeutic exposure
AU - E. Cloves
AU - S. A. Kamil
AU - N. Mayassi
AU - A. Pinto
AU - R. Karshafian
AU - C. N. Antonescu
AU - R. J. Botelho
PY - 2026
DA - 2026/10/17
PB - bioRxiv
DO - 10.64898/2026.10.17.759693
UR - https://www.biorxiv.org/content/10.64898/2026.10.17.759693v1
AB - Ultrasound-stimulated microbubble (USMB) sonoporation treatment is an emerging strategy for cancer therapy that enhances drug delivery by perforating the plasma membrane. This membrane permeabilization also causes cellular metabolic stress as cells leak metabolites such as ATP and amino acids. Collectively, cells may die in response to excess membrane damage and stress. However, many cells survive the USMB insult by engaging membrane repair and adaptation pathways such as stimulation of AMPK. In this study, we investigated the impact of USMB treatment on mitochondria and their role in post-exposure cellular survival. We found that USMB causes mitochondrial fragmentation and decreases mitochondrial membrane potential. Subsequently, autophagy and Parkin-dependent mitophagy are triggered post-USMB treatment in an AMPK-dependent mechanism. Importantly, Parkin silencing and PINK1 inhibition augment cell death when combined with USMB exposure, suggesting that mitophagy is an important cell survival process in response to USMB. We propose that combining USMB with inhibitors of mitophagy and metabolic stress adaptation is a strong candidate for therapeutic development to treat solid tumours.
ER -